Growth Metrics

Edwards Lifesciences (EW) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $598.2 million.

  • Edwards Lifesciences' Non-Current Debt rose 11.72% to $598.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $598.2 million, marking a year-over-year increase of 11.72%. This contributed to the annual value of $597.7 million for FY2024, which is 11.73% up from last year.
  • Edwards Lifesciences' Non-Current Debt amounted to $598.2 million in Q3 2025, which was up 11.72% from $598.0 million recorded in Q2 2025.
  • Edwards Lifesciences' Non-Current Debt's 5-year high stood at $598.2 million during Q3 2025, with a 5-year trough of $595.2 million in Q1 2021.
  • In the last 5 years, Edwards Lifesciences' Non-Current Debt had a median value of $596.7 million in 2023 and averaged $596.7 million.
  • As far as peak fluctuations go, Edwards Lifesciences' Non-Current Debt grew by 11.77% in 2021, and later increased by 10.05% in 2025.
  • Over the past 5 years, Edwards Lifesciences' Non-Current Debt (Quarter) stood at $595.7 million in 2021, then grew by 0.1% to $596.3 million in 2022, then increased by 0.12% to $597.0 million in 2023, then increased by 0.12% to $597.7 million in 2024, then rose by 0.08% to $598.2 million in 2025.
  • Its Non-Current Debt stands at $598.2 million for Q3 2025, versus $598.0 million for Q2 2025 and $597.8 million for Q1 2025.